Biotalys NV (EBR: BTLS)

Market Cap	99.37M
Revenue (ttm)	n/a
Net Income (ttm)	-16.34M
Shares Out	32.16M
EPS (ttm)	-0.51
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,597
Open	3.000
Previous Close	2.980
Day's Range	2.980 - 3.090
52-Week Range	1.620 - 5.680
Beta	0.96
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 5, 2024

About Biotalys NV

Biotalys NV, an agricultural technology company, discovers and develops novel biological products in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; and BIOFUN-4 targeting oomycetes in fruits and vegetables. The company was formerly known as Agrosavfe NV. Biotalys NV was incorporated in 2013 and...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2013
• Employees: 75
• Stock Exchange: Euronext Brussels
• Ticker Symbol: BTLS

Financial Performance

In 2023, Inclusio's revenue was 13.83 million, an increase of 24.87% compared to the previous year's 11.07 million. Earnings were 32.18 million, an increase of 44.75%.